Interaction between tiotropium bromide and olodaterol in human bronchial smooth muscle

M. Cazzola (Roma, Rm, Italy)

Source: International Congress 2017 – Bronchodilators and bronchoprotectors
Session: Bronchodilators and bronchoprotectors
Session type: Poster Discussion
Number: 1810
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Cazzola (Roma, Rm, Italy). Interaction between tiotropium bromide and olodaterol in human bronchial smooth muscle. 1810

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Interaction between tiotropium  bromide and olodaterol in small human airways
Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology
Year: 2017

Pharmacological interaction between glycopyrronium bromide and indacaterol fumarate on the human airways tone
Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action
Year: 2016

Interaction between aclidinium bromide and formoterol fumarate; effects on human bronchial smooth muscle
Source: International Congress 2014 – Novel evidence relating to respiratory treatment development
Year: 2014

Synergistic effects between glycopyrronium bromide and indacaterol on a muscarinic agonist-induced contraction in airway smooth muscle
Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD
Year: 2012


Role of budesonide, formoterol fumarate and aclidinium bromide in the inflammaging of airway epithelial cells
Source: International Congress 2017 – Cigarette smoke and particulate matter: basic science and clinical aspects
Year: 2017

Influence of tiotropium bromide and formoterol on bronchial hyperresponsiveness in COPD
Source: Annual Congress 2012 - COPD treatment and varia
Year: 2012


Pharmacological characterization of the mechanism of action leading to synergism between glycopyrronium bromide and indacaterol fumarate
Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action
Year: 2016

A comparison of beta2-adrenoceptor desensitisation induced by olodaterol and formoterol in human lung mast cells and airway smooth muscle cells
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013

Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013

Inhibitory effects of formoterol, budesonide and tiotropium bromide on human neutrophils in vitro
Source: Eur Respir J 2003; 22: Suppl. 45, 286s
Year: 2003

Combination study of tiotropium and olodaterol in human precision-cut lung slices
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013


The dual PDE3/PDE4 phosphodiesterase inhibitor RPL554 produces more complete bronchodilator responses than the beta2-agonist salbutamol and the anti-muscarinic agent ipratropium bromide, alone and in combination, in guinea-pig isolated trachea
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015


Comparative study of the effects of tiotropium bromide and budesonide on allergen-induced airway remodeling
Source: Eur Respir J 2006; 28: Suppl. 50, 434s
Year: 2006

Interaction between aclidinium bromide and formoterol fumarate in small human airways
Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases
Year: 2014

The combination therapy with inhaled tiotropium bromide and transdermal tulobuterol in COPD improves the peripheral airway function
Source: Annual Congress 2010 - Bronchodilator treatment for asthma and COPD
Year: 2010

Pulmonary function and bronchodilator response to albuterol, ipratropium bromide and association of albuterol and ipratropium bromide in children with cystic fibrosis (CF)
Source: Eur Respir J 2003; 22: Suppl. 45, 229s
Year: 2003

Effect of indacaterol, a novel long-acting β2-agonist, on isolated human bronchi
Source: Eur Respir J 2007; 29: 575-581
Year: 2007



Airway tone during exercise in healthy subjects: effects of salbutamol and ipratropium bromide
Source: Eur Respir J 2003; 22: Suppl. 45, 89s
Year: 2003

Cardiopulmonary effects of inhaled ipratropium bromide and its combination with fenoterol in patients with bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 58s
Year: 2002

Bronchodilator activity of the combination of salbutamol hemisuccinate and methatropium iodide compared with monotherapy in preclinical studies
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015